Trials / Sponsors / Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subject Ventilator Associated Pneumonia, Staphylococcus Aureus | Phase 3 | 2022-09-02 |
| Completed | Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 Lung Infection, Pneumonia, Ventilator-Associated, Infection, Bacterial | Phase 3 | 2019-05-03 |
| Unknown | SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects Cystic Fibrosis | Phase 1 / Phase 2 | 2018-12-07 |
| Completed | Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia Pseudomonas Aeruginosa Pneumonia | Phase 2 | 2017-03-29 |
| Completed | Study of Single Doses of IV Aerucin in Healthy Adults Healthy | Phase 1 | 2015-04-01 |
| Completed | Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus) Pneumonia Due to Staphylococcus Aureus | Phase 1 / Phase 2 | 2012-05-01 |